- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting sphingosine kinase-1 to inhibit melanoma
Authors
Keywords
-
Journal
Pigment Cell & Melanoma Research
Volume 25, Issue 2, Pages 259-274
Publisher
Wiley
Online
2012-01-12
DOI
10.1111/j.1755-148x.2012.00970.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sphingosine Kinase-1 Enhances Resistance to Apoptosis through Activation of PI3K/Akt/NF- B Pathway in Human Non-Small Cell Lung Cancer
- (2011) L. Song et al. CLINICAL CANCER RESEARCH
- Mechanisms of Resistance to RAF Inhibitors in Melanoma
- (2011) Andrew E. Aplin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer
- (2011) J. W. Antoon et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Resistance to BRAF Inhibition in Melanomas
- (2011) David B. Solit et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sphingosine Kinase 1 Regulates the Akt/FOXO3a/Bim Pathway and Contributes to Apoptosis Resistance in Glioma Cells
- (2011) Hongyu Guan et al. PLoS One
- Targeting the MAPK pathway in melanoma: Why some approaches succeed and other fail
- (2010) Gajanan S. Inamdar et al. BIOCHEMICAL PHARMACOLOGY
- Development of a sphingosine kinase 1 specific small-molecule inhibitor
- (2010) Jeremy A. Hengst et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A Novel Mode of Action of the Putative Sphingosine Kinase Inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) Thiazole (SKI II): Induction of Lysosomal Sphingosine Kinase 1 Degradation
- (2010) Shuyu Ren et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Combined anticancer effects of sphingosine kinase inhibitors and sorafenib
- (2010) Vladimir Beljanski et al. INVESTIGATIONAL NEW DRUGS
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis
- (2010) C Nogueira et al. ONCOGENE
- PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas
- (2010) John T. Lee et al. Pigment Cell & Melanoma Research
- Regulation of sphingosine kinase and sphingolipid signaling
- (2010) Stuart M. Pitson TRENDS IN BIOCHEMICAL SCIENCES
- Enhancement of sphingosine kinase 1 catalytic activity by deletion of 21 amino acids from the COOH-terminus
- (2009) Jeremy A. Hengst et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Targeting Sphingosine Kinase 1 Inhibits Akt Signaling, Induces Apoptosis, and Suppresses Growth of Human Glioblastoma Cells and Xenografts
- (2009) D. Kapitonov et al. CANCER RESEARCH
- Sphingosine Kinase 1 Is Associated with Gastric Cancer Progression and Poor Survival of Patients
- (2009) W. Li et al. CLINICAL CANCER RESEARCH
- Sphingosine Kinase Isoforms Regulate Oxaliplatin Sensitivity of Human Colon Cancer Cells through Ceramide Accumulation and Akt Activation
- (2009) Satoshi Nemoto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Use of high performance liquid chromatography-electrospray ionization-tandem mass spectrometry for the analysis of ceramide-1-phosphate levels
- (2009) Dayanjan S. Wijesinghe et al. JOURNAL OF LIPID RESEARCH
- Hypoxia Enhances Sphingosine Kinase 2 Activity and Provokes Sphingosine-1-Phosphate-Mediated Chemoresistance in A549 Lung Cancer Cells
- (2009) S. E. Schnitzer et al. MOLECULAR CANCER RESEARCH
- AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1)
- (2009) Seung-Shick Shin et al. Pigment Cell & Melanoma Research
- The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma
- (2009) SubbaRao V. Madhunapantula et al. Pigment Cell & Melanoma Research
- The role of sphingosine kinase 1 in cancer: Oncogene or non-oncogene addiction?
- (2008) M VADAS BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Targeting V600EB-Raf and Akt3 Using Nanoliposomal-Small Interfering RNA Inhibits Cutaneous Melanocytic Lesion Development
- (2008) M. A. Tran et al. CANCER RESEARCH
- Is B-Raf a Good Therapeutic Target for Melanoma and Other Malignancies?
- (2008) S. V. Madhunapantula et al. CANCER RESEARCH
- Akt3 and Mutant V600EB-Raf Cooperate to Promote Early Melanoma Development
- (2008) M. Cheung et al. CANCER RESEARCH
- Sphingosine Kinase 1: A New Modulator of Hypoxia Inducible Factor 1 during Hypoxia in Human Cancer Cells
- (2008) I. Ader et al. CANCER RESEARCH
- Combining Nanoliposomal Ceramide with Sorafenib Synergistically Inhibits Melanoma and Breast Cancer Cell Survival to Decrease Tumor Development
- (2008) M. A. Tran et al. CLINICAL CANCER RESEARCH
- Targeting SphK1 as a New Strategy against Cancer
- (2008) Dai Shida et al. CURRENT DRUG TARGETS
- Melanoma Genetics and Therapeutic Approaches in the 21st Century: Moving from the Benchside to the Bedside
- (2008) Thomas L. Hocker et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Inhibition of PI3K-AKT-mTOR Signaling Sensitizes Melanoma Cells to Cisplatin and Temozolomide
- (2008) Tobias Sinnberg et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Synthesis and Anticancer Activity Comparison of Phenylalkyl Isoselenocyanates with Corresponding Naturally Occurring and Synthetic Isothiocyanates
- (2008) Arun K. Sharma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines
- (2008) Dongmei Guo et al. LEUKEMIA RESEARCH
- Sphingosine Kinases and Sphingosine-1-Phosphate Are Critical for Transforming Growth Factor -Induced Extracellular Signal-Regulated Kinase 1 and 2 Activation and Promotion of Migration and Invasion of Esophageal Cancer Cells
- (2008) A. V. Miller et al. MOLECULAR AND CELLULAR BIOLOGY
- Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models
- (2008) D. Pchejetski et al. MOLECULAR CANCER THERAPEUTICS
- PBISe, a novel selenium-containing drug for the treatment of malignant melanoma
- (2008) S. V. Madhunapantula et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search